Piramal Pharma Ltd (PPLPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003728, "name": "Piramal Pharma", "stock_name": "Piramal Pharma", "full_name": "Piramal Pharma Ltd", "name_url": "stocks-analysis/piramal-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "146.10", "chg": 3.2, "chgp": "2.24%", "dir": 1, "prev_price": "142.90", "mcapval": "19,347.00 Cr", "mcap": "Small Cap", "scripcode": 543635, "symbol": "PPLPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE0DK501011", "curr_date": "Apr 10", "curr_time": "", "bse_nse_vol": "24.63 lacs", "exc_status": "Active", "traded_date": "Apr 10, 2026", "traded_date_str": "2026 04 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/piramal-pharma-1003728-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Piramal Pharma Ltd Upgraded to Sell on Technical and Valuation Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-upgraded-to-sell-on-technical-and-valuation-improvements-3939034", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PiramalPharmaLt_mojoScore_3939034.png", "date": "2026-04-09 08:33:23", "description": "Piramal Pharma Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 8 April 2026, driven primarily by a shift in technical indicators and a more attractive valuation profile. Despite ongoing financial challenges and underperformance relative to the broader market, the company’s improved technical trend and discounted valuation metrics have prompted a reassessment of its outlook by analysts." }, { "title": "Piramal Pharma Ltd Sees Technical Momentum Shift Amid Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-sees-technical-momentum-shift-amid-mixed-market-returns-3938855", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PiramalPharmaLt_technicaldot_3938855.png", "date": "2026-04-09 08:06:42", "description": "Piramal Pharma Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook, as reflected in recent technical indicators. Despite a modest 2.02% gain in the latest session, the stock remains under pressure with a Mojo Grade of Sell, signalling cautious sentiment among investors amid mixed signals from key momentum and trend indicators." }, { "title": "Piramal Pharma Valuation Shifts to Attractive Amid Challenging Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-valuation-shifts-to-attractive-amid-challenging-market-returns-3936344", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PiramalPharmaLt_valuationdot_3936344.png", "date": "2026-04-08 08:01:03", "description": "Piramal Pharma Ltd has seen a notable shift in its valuation parameters, moving from fair to attractive territory despite ongoing sector headwinds and a challenging earnings outlook. The company’s price-to-earnings (P/E) ratio has plunged to an unprecedented negative level, while its price-to-book value (P/BV) remains modestly elevated compared to peers. This recalibration in valuation metrics offers investors a nuanced perspective on the stock’s price attractiveness relative to historical and industry benchmarks." }, { "title": "Piramal Pharma Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-strong-sell-3932884", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PiramalPharmaLt_mojoScore_3932884.png", "date": "2026-04-04 10:10:35", "description": "Piramal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 04 April 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Piramal Pharma Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-strong-sell-3909627", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_mojoScore_3909627.png", "date": "2026-03-24 10:10:41", "description": "Piramal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 February 2026, reflecting a shift from the previous 'Sell' grade. However, all fundamentals, returns, and financial metrics discussed here are current as of 24 March 2026, providing an up-to-date view of the stock's position in the market." }, { "title": "Piramal Pharma Ltd Falls to 52-Week Low of Rs 133 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-stock-falls-to-52-week-low-of-rs133-on-23-mar-2026-3908047", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_priceRelatedfactors_3908047.png", "date": "2026-03-23 13:32:38", "description": "A sharp decline of 3.8% on 23 Mar 2026 dragged Piramal Pharma Ltd to a fresh 52-week low of Rs 133, extending a painful downtrend that has seen the stock lose over 41% in the past year, far outpacing the broader market's modest 5.5% decline." }, { "title": "Piramal Pharma Declines 1.21%: 2 Key Factors Behind the Weekly Slide", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-declines-121-2-key-factors-behind-the-weekly-slide-3905080", "imagepath": "", "date": "2026-03-21 11:03:19", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Mar:</strong> New 52-week low (Rs.134.8)</p>\n <p><strong>18 Mar:</strong> Valuation shifts signal attractive entry amid sector challenges</p>\n <p><strong>20 Mar:</strong> Week closes at Rs.138.25 (-1.21%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.139.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.138.25</div><div class=\"stat-change negative\">-1.21%</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week ..." }, { "title": "Piramal Pharma Ltd Valuation Shifts Signal Attractive Entry Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-valuation-shifts-signal-attractive-entry-amid-sector-challenges-3897967", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_valuationdot_3897967.png", "date": "2026-03-18 08:01:15", "description": "Piramal Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from fair to attractive territory despite ongoing challenges in its financial performance and stock returns. With a current price of ₹138.55, close to its 52-week low of ₹134.70, the pharmaceutical small-cap’s price-to-earnings (P/E) ratio has plunged to a striking -128.57, signalling significant earnings pressure. This article analyses the evolving valuation landscape of Piramal Pharma in comparison to its sector peers and historical benchmarks, providing a comprehensive view for investors navigating the Pharmaceuticals & Biotechnology space." }, { "title": "Piramal Pharma Ltd Stock Hits 52-Week Low Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3893807", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_priceRelatedfactors_3893807.png", "date": "2026-03-16 11:53:07", "description": "Piramal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.134.8 today, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics." } ], "total": 411, "sid": "1003728", "stock_news_url": "https://www.marketsmojo.com/news/piramal-pharma-1003728" }, "announcements": [ { "caption": "Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Rating", "datetime": "06-Apr-2026", "details": "Please refer attached file", "source": "BSE" }, { "caption": "Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015- Completion Of Acquisition Of Kenalog® A Branded Commercial Injectable Product", "datetime": "01-Apr-2026", "details": "Please refer attached file", "source": "BSE" }, { "caption": "Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Ratings", "datetime": "20-Mar-2026", "details": "Please refer attached file", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Piramal Pharma Ltd has declared <strong>1%</strong> dividend, ex-date: 16 Jul 25", "dt": "2025-07-16", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Piramal Pharma Ltd has announced <strong>5:46</strong> rights issue, ex-date: 02 Aug 23", "dt": "2023-08-02", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

16 Mar: New 52-week low (Rs.134.8)

18 Mar: Valuation shifts signal attractive entry amid sector challenges

20 Mar: Week closes at Rs.138.25 (-1.21%)

Read full news article

Piramal Pharma Ltd Valuation Shifts Signal Attractive Entry Amid Sector Challenges

2026-03-18 08:01:15

Piramal Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from fair to attractive territory despite ongoing challenges in its financial performance and stock returns. With a current price of ₹138.55, close to its 52-week low of ₹134.70, the pharmaceutical small-cap’s price-to-earnings (P/E) ratio has plunged to a striking -128.57, signalling significant earnings pressure. This article analyses the evolving valuation landscape of Piramal Pharma in comparison to its sector peers and historical benchmarks, providing a comprehensive view for investors navigating the Pharmaceuticals & Biotechnology space.

Read full news article

Piramal Pharma Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-03-16 11:53:07

Piramal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.134.8 today, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics.

Read full news article